NCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
Rigshospitalet, Denmark
Emory University
University of Pittsburgh
University of Arkansas
Rigshospitalet, Denmark
Instituto do Cancer do Estado de São Paulo
Tri-Service General Hospital